We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
-0.54%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.55B
AUM Growth
+$1.66B
Cap. Flow
+$1.48B
Cap. Flow %
41.7%
Top 10 Hldgs %
32.7%
Holding
1,519
New
774
Increased
208
Reduced
176
Closed
301
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEEV icon
1126
Veeva Systems
VEEV
$33.7B
$23.2K ﹤0.01%
127
-2,731
-96% -$542K
KLRS
1127
Kalaris Therapeutics
KLRS
$81.1M
$23K ﹤0.01%
+1,381
New +$24.4K
BHIL
1128
DELISTED
Benson Hill, Inc.
BHIL
$23K ﹤0.01%
+4,307
New +$28.5K
NDAQ icon
1129
Nasdaq
NDAQ
$53.8B
$21.3K ﹤0.01%
+354
New +$21.4K
AMWL icon
1130
American Well
AMWL
$184M
$21.2K ﹤0.01%
+3,270
New +$32.9K
WKHS icon
1131
Workhorse Group
WKHS
$33.6M
$21.1K ﹤0.01%
+90
New +$47.2K
UONE icon
1132
Urban One Class A
UONE
$23.1M
$20.9K ﹤0.01%
+1,048
New +$22.7K
UA icon
1133
Under Armour Class C
UA
$2.93B
$20.5K ﹤0.01%
+3,146
New +$20.8K
FOA icon
1134
Finance of America Companies
FOA
$217M
$20.2K ﹤0.01%
+4,089
New +$24.9K
BGXX
1135
DELISTED
Bright Green Corporation Common Stock
BGXX
$19.9K ﹤0.01%
+78,755
New +$19.5K
DZSI
1136
DELISTED
DZS Inc. Common Stock
DZSI
$19.2K ﹤0.01%
+16,400
New +$22.3K
RMD icon
1137
PUT
ResMed
RMD
$31B
$19.1K ﹤0.01%
+100
New +$20.3K
XAIR icon
1138
Beyond Air
XAIR
$3.92M
$18.7K ﹤0.01%
+87
New +$43.3K
DNMR
1139
DELISTED
Danimer Scientific, Inc.
DNMR
$18.4K ﹤0.01%
+763
New +$23.7K
OKUR
1140
OnKure Therapeutics
OKUR
$162M
$17.6K ﹤0.01%
+1,168
New +$19.8K
CAUD
1141
CALL
DELISTED
Collective Audience, Inc.. Common Stock
CAUD
$17.4K ﹤0.01%
32,002
MVST icon
1142
Microvast
MVST
$243M
$17K ﹤0.01%
+37,360
New +$16.8K
INSM icon
1143
Insmed
INSM
$22.5B
$16.1K ﹤0.01%
+240
New +$9.31K
BAC icon
1144
CALL
Bank of America
BAC
$435B
$15.9K ﹤0.01%
400
-17,764
-98% -$681K
PIII icon
1145
P3 Health Partners
PIII
$38.1M
$15.6K ﹤0.01%
+694
New +$20.7K
UONEK icon
1146
Urban One Class D
UONEK
$22M
$14.6K ﹤0.01%
+970
New +$16.2K
HUM icon
1147
Humana
HUM
$43.3B
$14.2K ﹤0.01%
38
-1,389
-97% -$469K
WY icon
1148
PUT
Weyerhaeuser
WY
$17.6B
$14.2K ﹤0.01%
+500
New +$15.5K
TVRD
1149
Tvardi Therapeutics
TVRD
$22.2M
$14.2K ﹤0.01%
+1,528
New +$36.5K
WOLF icon
1150
Wolfspeed
WOLF
$1.08B
$14K ﹤0.01%
616
-1,862
-75% -$48.2K

Similar funds

Paloma Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Paloma Partners held 1,519 positions worth $3.55B, up 88% from $1.89B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Paloma Partners deployed $1.48B of net new capital in Q2 2024, opening 774 new positions and adding to 208 existing holdings. Its largest new stake was Invesco QQQ Trust: 58,229 shares worth $27.9M.

By sector, the portfolio is most concentrated in Industrials at 3.8% of assets, up from 3% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P Metals & Mining ETF, an estimated $11M trimmed.

  • Paloma Partners's largest Q2 2024 buy was Invesco QQQ Trust: 58,229 shares worth $27.9M.
  • Paloma Partners added most to ConocoPhillips in Q2 2024, an estimated $12.6M increase.
  • Paloma Partners's biggest Q2 2024 reduction was State Street SPDR S&P Metals & Mining ETF, cutting an estimated $11M.
  • Paloma Partners fully exited Callon Petroleum Company in Q2 2024, selling an estimated $39.2M.
  • Paloma Partners's ten largest holdings make up 33% of its $3.55B portfolio in Q2 2024.
  • Paloma Partners opened 774 new positions and closed 301 in Q2 2024.
  • Paloma Partners's portfolio value rose 88% quarter-over-quarter to $3.55B.

Based on Paloma Partners's 13F filing for Q2 2024, filed 14 Aug 2024.